Tazarotene
Active substance: tazarotene
GEL · TAZAROTENE .5 mg/g
United StatesActive
Marketing holder: Solaris Pharma Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TAZAROTENE · .5 mg/g
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4a6e-73e2-9d43-a98e2c4a31b4,01a1208c-a648-700a-8cc8-f56e776db7ec,01a1208d-217b-7961-a3c3-07ab5c58d99c,01a1208d-217e-7cf6-a559-3c0d31016ebb,01a1208d-bff2-7ab3-9e9d-3e96d677bbb4;count=22 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73473-309
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- CUTANEOUS
Sources
- product · openFDA NDC · 73473-309 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73473-309 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73473-309 · Verified 2026-10-09 · open in source